Get Enquiry

Category Details :

The class of pharmaceuticals known as endothelin receptor antagonists (ERAs) has received a great deal of attention and significance in the fields of cardiovascular and pulmonary medicine. The endothelin receptor, a crucial participant in controlling blood vessel constriction and cellular development, is the target of these substances. The ETA and..

Read More
Enquiry Now